small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniDiversity, Equity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search

Capabilities 69 results

Practice Area

Product Liability & Mass Torts

Major multinational companies trust Winston to defend their products and reputations in high-profile, high-stakes product liability and mass tort claims. Our Product Liability & Mass Torts Practice is one of the industry’s most seasoned, with a deep bench of experienced lawyers and a unique combination of extensive trial experience and expansive technical knowledge....Read more

Industry

Energy Industry Litigation & Investigations

With our reputation as a trial lawyers’ firm serving as our foundation, we advocate for a variety of power producers, oil and gas companies, and oilfield services providers in high-stakes litigation throughout U.S. district and appellate courts. We also handle sensitive investigations, contentious regulatory and enforcement issues, and arbitration. Our bench is stacked with innovative legal and commercial problem solvers, many of whom came to Winston from in-house positions, amplifying their appreciation for C-suite complexities. By combining our knowledge of the energy industry with first-rate trial skills, and the experience our practitioners have gained from learning our clients’ businesses, we are positioned to obtain the best result for our clients efficiently—whether in the courtroom or a negotiated solution....Read more

Industry

Medical Devices

The medical device industry is currently undergoing monumental change—from supply chain challenges to disruptive technologies and economic fluctuations. To pave the way for a more accessible and innovative health care landscape—including advances in wearables, implants, diagnostics, mobility, drug delivery—the evolving and expansive medical device industry faces wide-ranging legal needs. Clients in this sector can tap the remarkable depth and breadth of our sector-focused and skilled attorneys in the U.S. and abroad. Our Health Care & Life Sciences Industry Group engages clients at all points in the product development life cycle to provide sound advice and practical solutions regardless of the client’s size or the complexity of their need. We help clients navigate today’s complex regulatory landscape, defend products and reputations in the face of high-profile product liability and mass tort claims, protect innovative intellectual property (IP), and leverage cross-border experience to advise on commercial transactions....Read more

Insights & News 1,265 results

Client Alert

|

December 5, 2024

|

10+ Min Read

CFPB Issues Open Banking Rule Making It Easier for Customers to “Divorce” Their Banks

On October 22, 2024, the Consumer Financial Protection Bureau (CFPB) issued a final rule to enforce consumers’ personal financial data access rights granted to them by Section 1033 of the Consumer Financial Protection Act (CFPA), 12 U.S.C. § 5553 (the Rule). Commonly referred to as the “open banking” rule, the Rule is intended to offer consumers the ability to easily switch between providers of financial services and products, increase innovation and greater quality in services, and create baseline security standards for sharing and accessing information across the market....Read more

Non-Fungible Insights: Blockchain Decrypted

|

December 4, 2024

|

10 Min Read

DAOs Watch Out: Federal Court in California Decides a DAO Can Be a General Partnership

On November 18, 2024, in Samuels v. Lido DAO, the United States District Court for the Northern District of California denied some defendants’ motions to dismiss, finding that the plaintiff sufficiently alleged that a decentralized autonomous organization (DAO) is a partnership under California law, and consequently that these defendants may be liable as general partners. The court relied chiefly on the plaintiff’s argument that these defendants “meaningfully participated” in the DAO’s governance.

Sponsorship

|

December 3, 2024

Winston Sponsors, Bryce Cooper and Matt Saxon Speak at ACI Drug & Medical Device Conference

Winston & Strawn partners Bryce Cooper and Matt Saxon will present during ACI’s 29thAnnual Drug & Medical Device Litigation Conference in New York on December 3–4, 2024....Read more
View All Insights & News

Other Results 43 results

Site Content

What Is the BPCIA?

Congress enacted the Biologics Price Competition and Innovation Act (BPCIA) to provide an abbreviated pathway for biosimilars to gain FDA approval through submission of an abbreviated Biologics License Application (aBLA)....Read more

Site Content

What Is General Causation?

In the product liability context, general causation is the legal and scientific determination of whether the product in question has the inherent capability to cause the alleged injury under certain circumstances. Establishment of general causation is a critical aspect of a plaintiff’s case, and typically requires scientific evidence, such as epidemiology or toxicology, and expert testimony to establish a causal connection between the product’s design, manufacturing, or warnings and the injury or injuries at issue. As contrasted to specific causation, the focus in a general causation inquiry is on whether the product or exposure, as a general matter, can cause the type of injury claimed by the plaintiff. A general causation inquiry does not assess any facts unique to a particular plaintiff....Read more

Law Glossary

What Is a Safe Harbor?

A safe harbor is a legal provision in a statute or regulation that provides protection from a legal liability or other penalty when certain conditions are met....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2024. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceEqual Rights AmendmentLaw GlossaryNew Administration: The Transition Period UpdateWinston MinutePrivacy PolicyCookie PolicyNoticesSubscribeAttorney Advertising